Joint Satellite - Myometrium/Parturition/Preterm Birth International Collaborative (PREBIC) Satellite Meeting

Session I

Moderators: 
Young Ju Kim, MD, PhD
Texas Children's Hospital, Friendswood, TX, USA
PREBIC Global Board of Director

Nanbert Zhong, MD
Head of Human Genetics Labratory
New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA
PREBIC Global Board of Director

8:20 a.m. – 8:30 a.m.

Preterm Birth International Collaborative Activities
Elizabeth Bonney, MD
Secretary General, PREBIC
Department of Obstetrics and Gynecology
University of Vermont, Burlington, VT, USA

8:30 a.m. - 8:55 a.m.

Baby Talk and Baby Steps: Uncovering Microbial-Immune Conversations at the Maternal-Fetal Interface
Indira U. Mysorekar, PhD
Wagner Professor of Medicine, Chief of Basic and Translational Research, Vice-Chief, Section for Infectious Diseases, Alkek Department of Medicine,
Baylor College of Medicine, Houston, TX, USA

8:55 a.m. - 9:20 a.m.

Impact of Maternal Inflammation on pregnancy outcome and fetal development
Gil Mor, MD, PhD
Director, C.S. Mott Center, Department of Obstetrics & Gynecology,
Wayne State University, Detroit, MI, USA

9:20 a.m. - 9:50 a.m.

BREAK

Session II

Moderators:
Hanns Helmer, MD
Professor, Dept. Obstetrics and Maternal- Fetal Medicine
Medical University Vienna, Vienna, Austria
Past President – PREBIC

Calvin J. Hobel, MD
Professor, Dept. of Obstetrics, Gynecology, Maternal-Fetal Medicine
Cedars-Sinai Medical Center, Los Angeles, CA, USA
Past President – PREBIC

9:50 a.m. - 10:15 a.m.

Immune System Dynamics in Healthy and Pathological Pregnancies
Brice Gaudillière, MD, PhD
Assistant Professor of Anesthesiology
Stanford Department of Anesthesiology, Perioperative and Pain Medicine
Stanford University School of Medicine, Palo Alto, CA, USA

10:15 a.m. - 10:40 a.m.

COVID-19: The Evolution of a Pandemic in New York City
Cynthia Gyamfi-Bannerman, MD
President - PREBIC
Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Columbia University, New York City, NY, USA

10:40 a.m. - 11:30 a.m.

Calvin J. Hobel, MD “Keynote Lecture”
The Case for Prenatal Precision Medicine to Prevent Preterm Birth
Diana W. Bianchi, MD
Director, Eunice Kennedy Shriver
National Institute of Child Health and Human Development (NICHD), Bethesda, MD, USA

11:30 a.m. - 12:00 p.m.

Live stream Q&A with all speakers from morning session

12:00 p.m. - 1:15 p.m.

LUNCH BREAK

Session III

Moderators: 
Elizabeth Bonney, MD
Department of Obstetrics and Gynecology, University of Vermont, Burlington, VT
Secretary General, PREBIC

Sam Mesiano, PhD
Professor, Case Western Reserve University, Cleveland, OH
Treasurer, PREBIC

Rachel Tribe, PhD
Professor, Dept. of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK
Board of Directors, PREBIC Europe

1:15 p.m. - 1:40 p.m.

Impaired Autophagy and Proteinopathy in Adverse Pregnancy Outcomes
Surendra Sharma, MD, PhD
Professor of Pediatrics Director, Center of Excellence for Reproductive Health Women and Infants Hospital
Warren Alpert Medical School of Brown University, Providence, RI USA

1:40 p.m. - 2:05 p.m.

Exploring the Physiological Adaptations to Pregnancy - Can it Inform our Understanding of Preterm Birth?
Michael Taggart, PhD
Professor of Reproductive Sciences, Institute of Genetic Medicine
University of Newcastle, UK

2:05 p.m. - 2:30 p.m. 

Modelling Maternal Obesity: Identifying the Mechanism Behind Myometrial Contractile Dysfunction During Parturition
Matthew Elmes, PhD
Lecturer in Nutritional Biochemistry, Faculty of Science, Sutton Bonington Campus
University of Nottingham, Loughborough, Leicestershire, United Kingdom

2:30 p.m. - 2:55 p.m.

Targeting Progesterone Sensitisation for the Prevention of Preterm Birth
Jonathan Paul, PhD
Lecturer, School of Medicine and Public Health (Reproductive Medicine)
University of Newcastle, Australia

2:55 p.m. - 3:25 p.m.

BREAK

3:25 p.m. - 4:00 p.m.

Partnering with Industry for Drug Development
Theresa Ankamah, PharmD
VP, Medical Affairs
Covis Pharma US, Inc

4:00 p.m. - 4:30 p.m.

Live stream Q&A with all speakers from afternoon session